Načítá se...
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?
Understanding the etiopathological processes of Alzheimer’s disease (AD) in the preclinical and early clinical stages will be important in developing new therapeutic targets and biomarkers. There is growing consensus that nonamyloid targets will be necessary to reverse or slow AD progression. Lipido...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627378/ https://ncbi.nlm.nih.gov/pubmed/23606909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.12.59 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|